News from the healthcare data industry
Sensyne Health PLC (AIM:SENS), the clinical artificial intelligence (AI) company, announced two new partnership deals. The first is a one-year agreement with Exscientia “to leverage the deep learning AI capabilities of the Sensyne platform to study real-world health data,” a statement said. Exscientia will make an upfront payment for four…
By Mark McCarty The U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) has unveiled two guidances for the use of real-world evidence (RWE) in regulatory decision-making. The policy seems limited to pharmaceutical clinical trials, with no indication when it will be expanded to include medical technology. The MHRA noted that the consultation, which…
DENVER & BOSTON–(BUSINESS WIRE)–Palantir Technologies Inc. (NYSE: PLTR), a leading builder of operating systems for the modern enterprise, and Dewpoint Therapeutics (“Dewpoint”), the leading biomolecular condensates company, today announced a partnership for Palantir’s Foundry platform to help power Dewpoint’s efforts to discover treatments and cures for the most challenging diseases….
December 16, 2021 08:00 AM Eastern Standard Time TORONTO–(BUSINESS WIRE)–Self Care Catalysts, a digital health company that enables patient engagement, decentralized clinical research and the collection of real world evidence, released their official Commitment to Patients. “Our goal as a company has always been to humanize healthcare and drug development…
Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.comT&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the…
Real-world data from the PACIFIC-R trial (NCT03798535) evaluating durvalumab (Imfinizi) following chemoradiotherapy in patients with stage III, unresectable non–small cell lung cancer (NSCLC) provide evidence supporting the agent’s efficacy in this population, solidifying its role as a standard-of-care treatment, according to Nicolas Girard, MD, PhD. Study results showed that the…
DENVER (PRWEB) DECEMBER 17, 2021 Today, Maya Health (Maya PBC), the leading real-world data platform connecting psychedelic therapists, patients, and researchers, announced its successful raise of $4.3 million in its first investment rounds. The funding includes an $800,000 angel round and a subsequent $3.5 million in seed funding. Participants in the funding round…
December 16, 2021 COTA Team Majority of providers also believe all cancer clinical trials should include real-world data to ensure diverse representation in treatments. COTA announced insights from a study of practicing oncologists that found 83 percent of oncologists surveyed believe real-world data is critical to accelerating the development of…
Posted on December 17, 2021 Company poised to transform personalized drug development and clinical healthcare in 2022, following series of key pharma partnerships leveraging its leading genomics platform and global real-world data access network Latest partnership, with the Colorado Center for Personalised Medicine, could prove pivotal for identifying gene-drugs conflicts…
CAMBRIDGE, Mass., Dec. 16, 2021 /PRNewswire/ — ConcertAI, LLC (ConcertAI), a leader in enterprise artificial intelligence (AI) Software-as-a-Service (SaaS) and Real-world Evidence (RWE) solutions for life science companies and healthcare providers, announced today the issuing of its first ERACE research award grants to Dr. Samuel L. Washington III of the University of California, San Francisco and Dr. Sarah…